Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (471-480 of 1,137) with videos related to

Pageof 114
Sort By:
Circulation|June 13, 2018
Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)"Erin A Bohula, Stephen D Wiviott, Robert P Giugliano, et al.
Journal of Clinical Pharmacology|May 12, 2000
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarctionN B Modi, N L Fox, F W Clow, et al.
The American Journal of Cardiology|September 8, 2001
The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarctionP F Bray, C P Cannon, P Goldschmidt-Clermont, et al.
JAMA|August 21, 2007
Diabetes and mortality following acute coronary syndromesSean M Donahoe, Garrick C Stewart, Carolyn H McCabe, et al.
Diabetes, Obesity & Metabolism|January 5, 2019
Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative RegistryWenjun Fan, Yang Song, Silvio E Inzucchi, et al.
Journal of Thrombosis and Thrombolysis|December 13, 2006
Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trialFreek W A Verheugt, Gilles Montalescot, Marc S Sabatine, et al.
JAMA Network Open|April 18, 2020
Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial InfarctionSuzanne V Arnold, James A de Lemos, Yuyin Liu, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2010
G-protein beta3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 trialA O Maree, C Vangjeli, H Jneid, et al.
The American Journal of Cardiology|January 28, 2010
Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program)Amrut V Ambardekar, Gregg C Fonarow, David Dai, et al.
The Journal of Clinical Investigation|September 1, 1994
Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormonesW H Rodgers, L M Matrisian, L C Giudice, et al.
Pageof 114

Showing results (471-480 of 1,137) with videos related to

Sort By:
Pageof 114
Circulation|June 13, 2018
Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)"Erin A Bohula, Stephen D Wiviott, Robert P Giugliano, et al.
Journal of Clinical Pharmacology|May 12, 2000
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarctionN B Modi, N L Fox, F W Clow, et al.
The American Journal of Cardiology|September 8, 2001
The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarctionP F Bray, C P Cannon, P Goldschmidt-Clermont, et al.
JAMA|August 21, 2007
Diabetes and mortality following acute coronary syndromesSean M Donahoe, Garrick C Stewart, Carolyn H McCabe, et al.
Diabetes, Obesity & Metabolism|January 5, 2019
Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative RegistryWenjun Fan, Yang Song, Silvio E Inzucchi, et al.
Journal of Thrombosis and Thrombolysis|December 13, 2006
Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trialFreek W A Verheugt, Gilles Montalescot, Marc S Sabatine, et al.
JAMA Network Open|April 18, 2020
Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial InfarctionSuzanne V Arnold, James A de Lemos, Yuyin Liu, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2010
G-protein beta3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 trialA O Maree, C Vangjeli, H Jneid, et al.
The American Journal of Cardiology|January 28, 2010
Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program)Amrut V Ambardekar, Gregg C Fonarow, David Dai, et al.
The Journal of Clinical Investigation|September 1, 1994
Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormonesW H Rodgers, L M Matrisian, L C Giudice, et al.
Pageof 114